MarketPeel
Pricing
…
President, R&D & CMO
Harold Bernstein
Mon, Feb 2, 2026
Feb 2
exercised or converted securities in MAZE
15,000 shares @ $0.00
Decreased holdings by -4.80%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
MAZEMaze Therapeutics, Inc.
HealthcareBiotechnology
1D+3.31%
1W+4.98%
1M+10.48%
3M+17.39%
6M—
1Y—

Recent insider activity at MAZE

Aug 13Harold BernsteinSold$445.62kAug 3Jason V. ColomaSold$4.17kAug 3Jason V. ColomaSold$43.44kAug 3Jason V. ColomaSold$809.54kAug 3Jason V. ColomaSold$65.16kJul 29Atul DandekarSold$193.88kJul 29Atul DandekarSold$11.16kJul 1Jason V. ColomaSold$77.73k
Full MAZE profile →Harold Bernstein’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback